CAPOX (Russian Wikipedia)

Analysis of information sources in references of the Wikipedia article "CAPOX" in Russian language version.

refsWebsite

Global rank Russian rank

4^th place

6^th place

2^nd place

3^rd place

low place

719^th place

660^th place

1^st place

doi.org

Cassidy J., Tabernero J., Twelves C., Brunet R., Butts C., Conroy T., Debraud F., Figer A., Grossmann J., Sawada N., Schöffski P., Sobrero A., Van Cutsem E., Díaz-Rubio E. XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer. (англ.) // Journal of clinical oncology : official journal of the American Society of Clinical Oncology. — 2004. — Vol. 22, no. 11. — P. 2084—2091. — doi:10.1200/JCO.2004.11.069. — PMID 15169795. [исправить]

Capecitabine Combined with Oxaliplatin (CapOx) in Clinical Practice: How Significant is Peripheral Neuropathy? Архивная копия от 3 февраля 2016 на Wayback Machine D. J. Storey; M. Sakala; C. M. McLean; H. A. Phillips; L. K. Dawson; L. R. Wall; M. T. Fallon; S. Clive. Posted: 09/28/2010; Annals of Oncology. 2010;21(8):1657-1661. © 2010 Oxford University Press

Cassidy J., Tabernero J., Twelves C., Brunet R., Butts C., Conroy T., Debraud F., Figer A., Grossmann J., Sawada N., Schöffski P., Sobrero A., Van Cutsem E., Díaz-Rubio E. XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer. (англ.) // Journal of clinical oncology : official journal of the American Society of Clinical Oncology. — 2004. — Vol. 22, no. 11. — P. 2084—2091. — doi:10.1200/JCO.2004.11.069. — PMID 15169795. [исправить]

Capecitabine Combined with Oxaliplatin (CapOx) in Clinical Practice: How Significant is Peripheral Neuropathy? Архивная копия от 3 февраля 2016 на Wayback Machine D. J. Storey; M. Sakala; C. M. McLean; H. A. Phillips; L. K. Dawson; L. R. Wall; M. T. Fallon; S. Clive. Posted: 09/28/2010; Annals of Oncology. 2010;21(8):1657-1661. © 2010 Oxford University Press

Cassidy J., Tabernero J., Twelves C., Brunet R., Butts C., Conroy T., Debraud F., Figer A., Grossmann J., Sawada N., Schöffski P., Sobrero A., Van Cutsem E., Díaz-Rubio E. XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer. (англ.) // Journal of clinical oncology : official journal of the American Society of Clinical Oncology. — 2004. — Vol. 22, no. 11. — P. 2084—2091. — doi:10.1200/JCO.2004.11.069. — PMID 15169795. [исправить]